Vardarli I - Search Results

1

GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes.

Mentis N, Vardarli I, Köthe LD, Holst JJ, Deacon CF, Theodorakis M, Meier JJ, Nauck MA. Mentis N, et al. Among authors: vardarli i. Diabetes. 2011 Apr;60(4):1270-6. doi: 10.2337/db10-1332. Epub 2011 Feb 17. Diabetes. 2011. PMID: 21330636 Free PMC article. Clinical Trial.

2

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ. Nauck MA, et al. Among authors: vardarli i. Diabetologia. 2011 Jan;54(1):10-8. doi: 10.1007/s00125-010-1896-4. Epub 2010 Sep 25. Diabetologia. 2011. PMID: 20871975 Review.

3

Inhibition of DPP-4 with vildagliptin improved insulin secretion in response to oral as well as "isoglycemic" intravenous glucose without numerically changing the incretin effect in patients with type 2 diabetes.

Vardarli I, Nauck MA, Köthe LD, Deacon CF, Holst JJ, Schweizer A, Foley JE. Vardarli I, et al. J Clin Endocrinol Metab. 2011 Apr;96(4):945-54. doi: 10.1210/jc.2010-2178. Epub 2011 Jan 14. J Clin Endocrinol Metab. 2011. PMID: 21239518 Clinical Trial.

4

Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and "isoglycemic" intravenous glucose.

Vardarli I, Arndt E, Deacon CF, Holst JJ, Nauck MA. Vardarli I, et al. Diabetes. 2014 Feb;63(2):663-74. doi: 10.2337/db13-0805. Epub 2013 Nov 1. Diabetes. 2014. PMID: 24186866 Clinical Trial.

5

Comparative evaluation of incretin-based antidiabetic medications and alternative therapies to be added to metformin in the case of monotherapy failure.

Nauck MA, Vardarli I. Nauck MA, et al. Among authors: vardarli i. J Diabetes Investig. 2010 Apr 22;1(1-2):24-36. doi: 10.1111/j.2040-1124.2010.00004.x. J Diabetes Investig. 2010. PMID: 24843405 Free PMC article. Review.

6

Self-monitoring of blood glucose in diabetes mellitus: arguments for an individualized approach.

Nauck MA, El-Ouaghlidi A, Vardarli I. Nauck MA, et al. Among authors: vardarli i. Dtsch Arztebl Int. 2009 Sep;106(37):587-94. doi: 10.3238/arztebl.2009.0587. Epub 2009 Sep 11. Dtsch Arztebl Int. 2009. PMID: 19890425 Free PMC article. Review.

7

Genetic determinants predicting efficacy of glucose-lowering drugs?: a long way to go ..

Nauck MA, Vardarli I. Nauck MA, et al. Among authors: vardarli i. Diabetes Care. 2010 Sep;33(9):2123-5. doi: 10.2337/dc10-1263. Diabetes Care. 2010. PMID: 20805284 Free PMC article. No abstract available.

8

Insulin clearance and incretin hormones following oral and "isoglycemic" intravenous glucose in type 2 diabetes patients under different antidiabetic treatments.

Tura A, Göbl C, Vardarli I, Pacini G, Nauck M. Tura A, et al. Among authors: vardarli i. Sci Rep. 2022 Feb 15;12(1):2510. doi: 10.1038/s41598-022-06402-5. Sci Rep. 2022. PMID: 35169165 Free PMC article.

9

[46-year-old man with hypoglycemia after seizure. Insulinoma].

Vardarli I, Fenske A, Nauck MA, Jäckel E, Leitolf H. Vardarli I, et al. Dtsch Med Wochenschr. 2010 May;135(18):913-4. doi: 10.1055/s-0030-1253677. Epub 2010 Apr 27. Dtsch Med Wochenschr. 2010. PMID: 20425676 German. No abstract available.

10

Possible metabolic impact of Ramadan fasting in healthy men.

Vardarli MC, Hammes HP, Vardarli İ. Vardarli MC, et al. Among authors: vardarli i. Turk J Med Sci. 2014;44(6):1010-20. doi: 10.3906/sag-1308-30. Turk J Med Sci. 2014. PMID: 25552155 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page